Relay Therapeutics, Inc. SEC filings RLAY

Relay Therapeutics, Inc. has 556 filings in SEC EDGAR's recent list, going back to May 22, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Relay Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
4 Insider transaction Oct 30, 2026 Oct 28, 2026
4 Insider transaction Oct 30, 2026 Oct 28, 2026
4 Insider transaction Oct 30, 2026 Oct 28, 2026
4 Insider transaction Oct 8, 2026 Oct 7, 2026
4 Insider transaction Oct 8, 2026 Oct 6, 2026
144 Notice of proposed sale Oct 7, 2026 —
144 Notice of proposed sale Oct 6, 2026 —
4 Insider transaction Sep 9, 2026 Sep 8, 2026
4 Insider transaction Sep 9, 2026 Sep 8, 2026
4 Insider transaction Sep 9, 2026 Sep 8, 2026
4 Insider transaction Aug 28, 2026 Aug 26, 2026
4 Insider transaction Aug 28, 2026 Aug 25, 2026
144 Notice of proposed sale Aug 26, 2026 —
144 Notice of proposed sale Aug 25, 2026 —
4 Insider transaction Aug 18, 2026 Aug 17, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 7, 2026 —
424B5 Prospectus supplement Aug 6, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Material agreement, Results of operations
Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 6, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
144 Notice of proposed sale Jul 31, 2026 —
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
144 Notice of proposed sale Jul 21, 2026 —
144 Notice of proposed sale Jul 20, 2026 —
4 Insider transaction Jul 8, 2026 Jul 6, 2026
4 Insider transaction Jul 8, 2026 Jul 7, 2026
4 Insider transaction Jul 8, 2026 Jul 6, 2026
144 Notice of proposed sale Jul 7, 2026 —
4 Insider transaction Jul 2, 2026 Jun 30, 2026
144 Notice of proposed sale Jun 30, 2026 —
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
144 Notice of proposed sale Jun 22, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 9, 2026 Jun 9, 2026
8-K Current report
Material agreement
May 21, 2026 May 20, 2026
424B5 Prospectus supplement May 21, 2026 —
424B5 Prospectus supplement May 19, 2026 —
8-K Current report
Regulation FD disclosure, Other events
May 19, 2026 May 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 14, 2026 May 14, 2026
144 Notice of proposed sale May 14, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 9, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 27, 2026 Apr 27, 2026
PRE 14A Preliminary proxy statement Apr 16, 2026 Jun 9, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 13, 2026 —
4 Insider transaction Apr 9, 2026 Apr 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 19, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Mar 16, 2026 Mar 16, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
8-K Current report
Bylaw or fiscal year change
Mar 11, 2026 Mar 6, 2026
144 Notice of proposed sale Mar 9, 2026 —
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Feb 3, 2026 Feb 3, 2026
4 Insider transaction Jan 29, 2026 Jan 27, 2026
4 Insider transaction Jan 29, 2026 Jan 27, 2026
4 Insider transaction Jan 29, 2026 Jan 27, 2026
4 Insider transaction Jan 15, 2026 Jan 13, 2026
4 Insider transaction Jan 15, 2026 Jan 13, 2026
4 Insider transaction Jan 15, 2026 Jan 13, 2026
4 Insider transaction Jan 15, 2026 Jan 13, 2026
4 Insider transaction Jan 7, 2026 Jan 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 6, 2025 Nov 4, 2025
4 Insider transaction Nov 6, 2025 Nov 4, 2025
3 Initial insider ownership Nov 6, 2025 Nov 4, 2025
3 Initial insider ownership Nov 6, 2025 Nov 4, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Nov 6, 2025 Nov 4, 2025
4 Insider transaction Nov 4, 2025 Nov 3, 2025
4 Insider transaction Oct 30, 2025 Oct 28, 2025
4 Insider transaction Oct 30, 2025 Oct 28, 2025
4 Insider transaction Oct 30, 2025 Oct 28, 2025
144 Notice of proposed sale Oct 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
4 Insider transaction Jul 10, 2025 Jul 9, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
3 Initial insider ownership Jun 11, 2025 Jun 9, 2025
8-K Current report
Officer or director change
Jun 11, 2025 Jun 8, 2025
4 Insider transaction Jun 6, 2025 Jun 6, 2025
4 Insider transaction Jun 6, 2025 Jun 6, 2025
4 Insider transaction Jun 6, 2025 Jun 6, 2025
4 Insider transaction Jun 6, 2025 Jun 6, 2025
4 Insider transaction Jun 6, 2025 Jun 6, 2025
4 Insider transaction Jun 6, 2025 Jun 6, 2025
8-K Current report
Shareholder vote results
Jun 6, 2025 Jun 6, 2025
8-K Current report
Material agreement, Agreement ended
Jun 4, 2025 Jun 3, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 5, 2025 May 5, 2025
4 Insider transaction Apr 30, 2025 Apr 28, 2025
4 Insider transaction Apr 30, 2025 Apr 28, 2025
4 Insider transaction Apr 30, 2025 Apr 28, 2025
4 Insider transaction Apr 30, 2025 Apr 28, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 30, 2025 —
144 Notice of proposed sale Apr 29, 2025 —
144 Notice of proposed sale Apr 28, 2025 —
4 Insider transaction Apr 24, 2025 Apr 23, 2025
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Jun 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
4 Insider transaction Mar 31, 2025 Mar 27, 2025
4 Insider transaction Mar 31, 2025 Mar 27, 2025
4 Insider transaction Mar 31, 2025 Mar 27, 2025
4 Insider transaction Mar 31, 2025 Mar 27, 2025
144 Notice of proposed sale Mar 27, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Mar 20, 2025 —
S-8 Employee stock plan registration Feb 26, 2025 —
10-K Annual report Feb 26, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
4 Insider transaction Feb 13, 2025 Feb 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2025 —
4 Insider transaction Jan 30, 2025 Jan 28, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
144 Notice of proposed sale Jan 29, 2025 —
144 Notice of proposed sale Jan 28, 2025 —
4 Insider transaction Jan 23, 2025 Jan 21, 2025
144 Notice of proposed sale Jan 23, 2025 —
144 Notice of proposed sale Jan 22, 2025 —
144 Notice of proposed sale Jan 21, 2025 —
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
4 Insider transaction Jan 14, 2025 Jan 10, 2025
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 3, 2025 —
4 Insider transaction Dec 31, 2024 Dec 27, 2024
4 Insider transaction Dec 31, 2024 Dec 27, 2024
4 Insider transaction Dec 31, 2024 Dec 27, 2024
4 Insider transaction Dec 31, 2024 Dec 27, 2024
144 Notice of proposed sale Dec 27, 2024 —
4 Insider transaction Dec 18, 2024 Dec 16, 2024
144 Notice of proposed sale Dec 16, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Dec 11, 2024 Dec 11, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
4 Insider transaction Oct 30, 2024 Oct 28, 2024
4 Insider transaction Oct 30, 2024 Oct 28, 2024
4 Insider transaction Oct 30, 2024 Oct 28, 2024
4 Insider transaction Oct 30, 2024 Oct 28, 2024
144 Notice of proposed sale Oct 29, 2024 —
144 Notice of proposed sale Oct 28, 2024 —
4 Insider transaction Oct 1, 2024 Sep 27, 2024
4 Insider transaction Oct 1, 2024 Sep 27, 2024
4 Insider transaction Oct 1, 2024 Sep 27, 2024
4 Insider transaction Oct 1, 2024 Sep 27, 2024
144 Notice of proposed sale Sep 27, 2024 —
8-K Current report
Material agreement, Other events
Sep 11, 2024 Sep 9, 2024
424B5 Prospectus supplement Sep 11, 2024 —
424B5 Prospectus supplement Sep 9, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Sep 9, 2024 Sep 9, 2024
S-3ASR Automatic shelf registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Jul 31, 2024 Jul 29, 2024
4 Insider transaction Jul 31, 2024 Jul 29, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
RLAY (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Large accelerated filer
SEC CIK
1812364

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.